Am J Clin Oncol 2021 Apr 13. Epub 2021 Apr 13.
Department of Radiation Oncology, University of Washington Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA Department of Radiation Oncology, University of Maryland School of Medicine and Maryland Proton Treatment Center, Baltimore, MD Oklahoma Proton Center, Oklahoma City, OK Procure Proton Therapy Center, Somerset, NJ Department of Radiation Oncology, Willis-Knighton Cancer Center, Shreveport, LA Northwestern Medicine Proton Center, Warrenville, IL Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ Department of Radiation Oncology, Scripps Health, San Diego, CA Department of Radiation Oncology, Emory Winship Cancer Institute, Atlanta, GA Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY Department of Radiation Oncology, Beaumont Health, Royal Oak, MI.
Purpose: As patients with mediastinal lymphoma are typically young with curable disease, advanced radiation techniques such as proton therapy are often considered to minimize subacute and late toxicity. However, it is unclear which mediastinal lymphoma patients are treated with proton therapy. Within a prospective, multi-institutional proton registry, we characterized mediastinal lymphoma patients treated with proton therapy and assessed concordance with consensus recommendations published in 2018 by the International Lymphoma Radiation Oncology Group (ILROG). Read More